| Representative coexpressed gene network |

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| hsa05200 |
Pathways in cancer |
16 |
 |
| hsa05218 |
Melanoma |
15 |
 |
| hsa05214 |
Glioma |
12 |
 |
| hsa05226 |
Gastric cancer |
12 |
 |
| hsa04010 |
MAPK signaling pathway |
11 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mmu05200 |
Pathways in cancer |
25 |
 |
| mmu05218 |
Melanoma |
24 |
 |
| mmu05214 |
Glioma |
20 |
 |
| mmu05223 |
Non-small cell lung cancer |
19 |
 |
| mmu05225 |
Hepatocellular carcinoma |
19 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| rno05200 |
Pathways in cancer |
17 |
 |
| rno05218 |
Melanoma |
17 |
 |
| rno05214 |
Glioma |
16 |
 |
| rno05223 |
Non-small cell lung cancer |
14 |
 |
| rno05225 |
Hepatocellular carcinoma |
14 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mcc05200 |
Pathways in cancer |
13 |
 |
| mcc05218 |
Melanoma |
13 |
 |
| mcc05223 |
Non-small cell lung cancer |
11 |
 |
| mcc05225 |
Hepatocellular carcinoma |
11 |
 |
| mcc05224 |
Breast cancer |
10 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| cfa05200 |
Pathways in cancer |
12 |
 |
| cfa05218 |
Melanoma |
12 |
 |
| cfa04010 |
MAPK signaling pathway |
10 |
 |
| cfa05214 |
Glioma |
10 |
 |
| cfa05224 |
Breast cancer |
10 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| fca05200 |
Pathways in cancer |
19 |
 |
| fca05218 |
Melanoma |
18 |
 |
| fca04010 |
MAPK signaling pathway |
15 |
 |
| fca05226 |
Gastric cancer |
15 |
 |
| fca05214 |
Glioma |
15 |
 |
|
| Gene list in the network |
|
|
Symbol |
Function* |
| |
Akt1 |
thymoma viral proto-oncogene 1 |
| |
Akt2 |
thymoma viral proto-oncogene 2 |
| |
Araf |
Araf proto-oncogene, serine/threonine kinase |
| |
Bak1 |
BCL2-antagonist/killer 1 |
| |
Bax |
BCL2-associated X protein |
| |
Ccng1 |
cyclin G1 |
| |
Cdk6 |
cyclin-dependent kinase 6 |
| |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
| |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
| |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
| |
Ednra |
endothelin receptor type A |
| |
Egfr |
epidermal growth factor receptor |
| |
Fgf18 |
fibroblast growth factor 18 |
| |
Gpc4 |
glypican 4 |
| |
Hgf |
hepatocyte growth factor |
| |
Hras |
Harvey rat sarcoma virus oncogene |
| |
Mbd3 |
methyl-CpG binding domain protein 3 |
| |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
| |
Met |
met proto-oncogene |
| |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
| |
Nras |
neuroblastoma ras oncogene |
| |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
| |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
| |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
| |
Trp53 |
transformation related protein 53 |
| |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
| |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
| |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
| |
Polk |
polymerase (DNA directed), kappa |
| |
Phlda3 |
pleckstrin homology like domain, family A, member 3 |
| |
Pdgfc |
platelet-derived growth factor, C polypeptide |
| |
Mtch1 |
mitochondrial carrier 1 |
| |
Taz |
tafazzin |
| |
Raver1 |
ribonucleoprotein, PTB-binding 1 |
| |
Csnk1g2 |
casein kinase 1, gamma 2 |
| |
Ddb2 |
damage specific DNA binding protein 2 |
|
|
Symbol |
Function* |
| |
Hgf |
hepatocyte growth factor |
| |
Nras |
NRAS proto-oncogene, GTPase |
| |
Pdgfrb |
platelet derived growth factor receptor beta |
| |
Tp53 |
tumor protein p53 |
| |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
| |
Pdgfra |
platelet derived growth factor receptor alpha |
| |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
| |
Map2k2 |
mitogen activated protein kinase kinase 2 |
| |
Mtpn |
myotrophin |
| |
Cdk4 |
cyclin-dependent kinase 4 |
| |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
| |
Bak1 |
BCL2-antagonist/killer 1 |
| |
Mapk1 |
mitogen activated protein kinase 1 |
| |
Map2k1 |
mitogen activated protein kinase kinase 1 |
| |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
| |
Hras |
HRas proto-oncogene, GTPase |
| |
Raver1 |
ribonucleoprotein, PTB-binding 1 |
| |
Abhd17a |
abhydrolase domain containing 17A, depalmitoylase |
| |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
| |
Mdm2 |
MDM2 proto-oncogene |
| |
Dcakd |
dephospho-CoA kinase domain containing |
| |
Aen |
apoptosis enhancing nuclease |
| |
Relt |
RELT, TNF receptor |
| |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
| |
E2f2 |
E2F transcription factor 2 |
|
|
|
|